Medical Oncologist
CION Cancer Clinics
When tablets or infusions become the main treatment for liver cancer | CION Cancer Clinics
Medicines become the main treatment for liver cancer when it has grown beyond what surgery, ablation or TACE can reach, and the liver can still cope with the drugs. This usually means spread outside the liver, tumour in a main vein, or cancer that local treatment no longer controls. This page explains how the team decides, and who it does not suit. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- When does medicine become the main treatment for liver cancer?
- What does the tumour board look at before switching to medicines?
- In which situations do doctors turn to tablets or infusions?
- How is medicine different from treating the liver directly?
- Who is systemic treatment not the right next step for?
- What this page cannot tell you
- Common questions about starting systemic treatment
The short answer
When does medicine become the main treatment for liver cancer?
Tablets or infusions become the main treatment when the cancer has grown beyond what surgery, ablation or TACE can reach, and the liver is still working well enough to cope with the drugs. In practice that usually means cancer that has spread outside the liver, cancer growing into a main blood vessel, or cancer that keeps coming back after local treatment.
Who this page is for
It is for families of someone with hepatocellular carcinoma (HCC), the cancer that starts in the liver cells, who have been told that "medicines are the next step". If the cancer started somewhere else, such as the bowel or breast, and spread to the liver, medicines often come first for a different reason. Read why systemic treatment usually comes first in secondary cancer.
Why the word "main" matters
Moving to medicines does not mean the team has given up. It means the treatment needs to reach cancer wherever it is in the body, rather than one spot in the liver. Local treatments may still be added later for a single problem area, and symptom care runs alongside throughout.
What the team weighs
What does the tumour board look at before switching to medicines?
Three things decide it together. A change in any one of them can move the plan.
The tumour
How many tumours there are, where they sit, and whether the cancer has reached the lungs, bones, lymph nodes or the portal vein, the main vein carrying blood into the liver. Spread beyond the liver is the clearest sign that a local treatment alone is not enough.
The liver
Most people with HCC also have cirrhosis, meaning scarring of the liver. Bilirubin, albumin, clotting tests, fluid in the abdomen and any confusion are combined into a Child-Pugh score. Medicines work best, and are safest, when liver function is well preserved.
The person
How active you are, your heart, kidneys and blood pressure, any autoimmune illness, a past transplant, and what matters to you. A person who spends most of the day in bed may be harmed more than helped.
Also checked
- Hepatitis B or C status
- Varices on endoscopy
- Other medicines you take
Not sure whether this applies to you?
Ask an oncologistThe usual situations
In which situations do doctors turn to tablets or infusions?
-
The cancer has spread outside the liver
Once cancer is found in the lungs, bones or distant lymph nodes, it needs a treatment that travels through the blood. This is the stage doctors call BCLC C, or advanced. See BCLC stage C.
-
The cancer has grown into a main blood vessel
Tumour inside the portal vein makes surgery and TACE riskier and less useful. Medicines become the backbone, sometimes with radiation or another local treatment added for that vessel.
-
The liver tumours are too many or too large for TACE
Intermediate-stage cancer is usually treated with TACE first. When the tumours are spread through much of the liver, or TACE has been repeated without control, medicines usually take over. Read about TACE combined with systemic treatment.
-
The cancer has come back after local treatment
If HCC returns after surgery or ablation in a way local treatment cannot handle again, medicines are usually next. After a liver transplant, immunotherapy is generally avoided, so tablets are used instead.
-
A local treatment is not safe for you
Sometimes the tumour could in theory be treated locally, but other illness, the tumour's position or the blood supply make it unsafe. Medicines can then be the main plan.
Side by side
How is medicine different from treating the liver directly?
Local treatment: surgery, ablation, TACE
Systemic treatment: tablets or infusions
Aims at the tumours you can see on the scan
Reaches cancer anywhere in the body
Coordinated through partner hospitals and interventional radiologists
Given at CION centres, by drip or as tablets at home
Surgery and ablation can be curative for early cancer
Usually aims to control the cancer, not remove it
Each treatment is one event, sometimes repeated
Continues as long as it works and is tolerated
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Not for everyone
Who is systemic treatment not the right next step for?
It does not suit people with early cancer that can still be removed, burnt away or treated with a transplant. Those treatments offer a chance of curative treatment that medicines alone cannot match, so they come first. If you have been offered medicines for a small, single tumour, it is reasonable to ask why.
When the liver is failing
It also does not suit people whose liver is failing, with deep jaundice, fluid that keeps building up or repeated confusion. This is sometimes called BCLC stage D. Here the drugs carry more risk than benefit, and care focuses on comfort and quality of life. Read about BCLC stage D.
When the person is too unwell
Someone who is weak, bedbound or seriously ill from another condition may not gain from medicines. Choosing not to start is a real decision, not a failure, and palliative care can still do a great deal.
Some people with moderately reduced liver function, Child-Pugh B, can still be treated with care. That is a judgement for your oncologist.
Did you know
Many families cut protein from the diet of someone with liver disease, fearing it harms the liver. Most people with cirrhosis need enough protein to stay strong, and strength is one of the things that decides whether medicines can be given. Ask before you change the diet.
Being straight with you
What this page cannot tell you
It cannot tell you whether your cancer has reached this point. That depends on a recent scan read by a radiologist, your blood tests and a tumour board that has looked at all of it together. A phrase on a report such as "multiple lesions" does not on its own decide the plan.
It cannot choose the medicine
Which drug comes first depends on your liver, your bleeding risk, your other illnesses and what is available in India at the time. The options page sets out the choices. Your oncologist makes the match.
It cannot predict how you will do
No page can give an individual outlook. Ask your oncologist how they will tell whether treatment is working, and what happens next if it is not.
If you have been told medicines are the next step and want the decision checked, a second opinion is a normal and sensible request.Questions we are asked
Common questions about starting systemic treatment
Does starting medicines mean the cancer cannot be treated any more?
No. It means the cancer is best treated with something that reaches the whole body. Many people live well on systemic treatment for a long time. If the cancer shrinks a great deal, the team may reconsider a local treatment later.
Can medicines be combined with TACE or radiation?
Sometimes. A single troublesome tumour, or cancer in a blood vessel, may be treated locally while medicines handle the rest. Whether a combination helps you is a tumour board decision, and some combinations are still being studied in trials.
Is it tablets or a drip?
Either. The usual first choice for most people is an immunotherapy combination given as a drip at a CION centre. Tablets such as lenvatinib or sorafenib are taken at home when immunotherapy is not safe, or later on. Your oncologist explains why one suits you.
What if my liver function gets worse during treatment?
Your blood tests are checked regularly for this reason. The dose may be lowered, treatment paused, or stopped if the liver cannot cope. Tell the team early about yellow eyes, swelling of the abdomen, drowsiness or new confusion.
Do I still need my hepatitis B tablets?
Usually yes, and do not stop them on your own. Hepatitis B is controlled, not cleared, and cancer treatment can make it flare. A hepatologist or physician manages the antiviral tablets alongside your oncologist.
Why was my father offered medicines when his tumour is only in the liver?
Cancer can be confined to the liver and still be too widespread, or too close to a main vein, for surgery or TACE to help. His liver function or general health may also make a local procedure unsafe. Ask the team to explain which of these applied.
Can we wait and decide later?
You can take time to talk it through as a family, and you should. But liver function can change, and the window for treatment can narrow. Ask your oncologist how much time is reasonable for your situation.
How do I get a second opinion on this decision?
Gather the latest scan images and report, recent blood tests and any endoscopy report. Call the CION helpline and ask for a medical oncology review. The tumour board can look at whether medicines are the right next step.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Treatment of Liver Cancer, by Stage
- National Cancer Institute — Liver Cancer Treatment
- Cancer Research UK — Treatment for liver cancer
- American Cancer Society — Targeted Drug Therapy for Liver Cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Systemic treatment for liver cancer: the options todayWhich medicines exist once this decision is madeBCLC stage C: advancedThe stage where medicines usually take overWhy Child-Pugh decides what treatment you can haveHow liver function opens or closes the optionsQuestions to ask before starting systemic treatmentA checklist for the first appointment
Talk to us
Told medicines are the next step and want it checked?
Share the latest scan and blood reports, and a medical oncologist can walk you through whether systemic treatment fits. One helpline serves every CION centre.